Navigation Links
Fred Hutchinson Cancer Research Center's Big Expedition for Cancer Research Team Returns From Reconnaissance Flight Over Alaska's Glacier Bay Park
Date:3/14/2008

Team finalizes choice of mountain and route for June expedition

SEATTLE, March 14 /PRNewswire/ -- Members from Fred Hutchinson Cancer Research Center's Big Expedition for Cancer Research got their first aerial look at the peak they will climb this summer. The group returned today from a photo flyover to plan a primary route up the unnamed and unclimbed mountain in Alaska's Glacier Bay National Park. The Big Expedition for Cancer Research is a quest sponsored by the Hutchinson Center to raise national awareness of cancer research.

The 8,300 foot mountain, which had not been seen by a mountaineer in more than 30 years, had only been viewed from one side, making planning for the expedition difficult. It is in a remote location and features a precipitous peak.

This June, a team of four professional climbers from across North America will scale the unnamed peak as the kick-off event of this national awareness campaign. The climb mirrors the quest to eliminate cancer -- the route is uncharted, there are inevitable unexpected setbacks and exhilarating advances, yet the goal remains paramount.

"The remoteness of the mountain makes this an expedition in the truest sense," said Kevin Mahoney, expedition member from Madison, New Hampshire. "It's a classic peak, but one that offers no easy routes. Its location adds to the challenge. As climbers, we are all excited to climb this peak in the name of cancer research."

Using Air Excursions flying service out of Juneau, Kevin Mahoney; Jim Wickwire, an experienced Alaska climber and member of the Mountaineering Advisory Committee; and Kit Herrod, director of public relations for the Hutchinson Center, were on board for the flyover to finalize the mountain choice and route.

"After more than three decades, it was exciting to see this area of the Fairweather Range again," said Jim Wickwire, who first viewed the mountain in the late 1970s while climbing in the area. "It is truly a stunni
'/>"/>

SOURCE Fred Hutchinson Cancer Research Center
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Hutchinson Center Announces First Unclimbed Mountain to be Tackled by Big Expedition for Cancer Research
2. Carreras Foundation to Endow Clinical-Research Chair at Fred Hutchinson Cancer Research Center
3. Fred Hutchinson Cancer Research Center Announces the First-Ever Expedition to an Unclimbed Mountain in the Name of Cancer Research
4. St. Jude finds signaling system that halts the growth of a childhood brain cancer
5. Combo Treatment Ups Survival When Cancer Spreads to Abdominal Lining
6. Obesity Linked to Poor Prognosis for Some Breast Cancer Patients
7. Vanessa Williams and Carmen Marc Valvo Make It Fashionable to Talk About Colon Cancer In New Public Service Announcement
8. Fighting Cancer With a Pen
9. Body Mass Index may serve as prognostic tool for advanced, aggressive breast cancers
10. Soy compound may halt spread of prostate cancer
11. Breast cancer more aggressive among obese women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...-USNewswire/ -- The Custom Briefings,network of Bu...e Endocrine,Daily Briefing, produced exclusively f...y., Endocrine Daily Briefing is emailed Monday th...ers, medical professionals engaged in the,fight ag...Endocrine Daily,Briefing joins a network of medica...
(Date:8/29/2008)...USNewswire/ -- The following is a,statement by Mat...e Kids:, For the second time in a month, Philip M...p and promotion of a concert in a developing count...engaging in cigarette,marketing that appeals to ch...as been forced to withdraw from,an August 30 reuni...
(Date:8/29/2008)...swire-FirstCall/ -- InterMune, Inc.,(Nasdaq: ITMN... CEO and,President of InterMune, will present at t... Boston on September 4, 2008 at 10:55 a.m. EDT., ..., investors and other,interested parties may log o...rporate website at http://www.intermune.com . The...
(Date:8/29/2008)...re Than 30 European Countries, HONOLULU, Aug. 29 ...y,that it has successfully completed the intensive...evice Directive (for most European Union countries...or Conformite Europeene Mark,-- for the LifeBed(TM...atient safety reach to include more than 30 countr...
Breaking Medicine News(10 mins):Health News:Custom Briefings Announces Launch of Endocrine Daily Briefing 2Health News:Philip Morris International Forced to Drop Another Concert Sponsorship; Philippines Health Department Applauded for Taking Action 2Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 2Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 3Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 4
...ng too many high-fat meals will clog arteries and ...ews that even a single high-fat meal can quickly s...ate pumping up of blood pressure levels could prov...rough which high fat meals produce heart disease o...
...ished in PLoS Medicine journal by Cambridge rese...t which a woman first menstruates.// These are he...eight and risk of obesity in later life. Research...ouncil and University of Cambridge, led by Dr Ken ...
...omen who drink more two bottles of wine over the w...breast cancer. // The study reported in the Europ...p of 17,647 nurses who drank 22-27 drinks a week c...e drinks, the risk of breast cancer was two times ...
...ble searing feeling in your stomach and chest, is ...According to researchers, modern day life with its...r sleep necessitates the purchase of fast foods an... root cause of the problem, they say. A study co...
Other Medicine News:Health News:A Single High Fat Meal Could Boost Blood Pressures 2Health News:Women Binge- Drinkers Warned Of Possible Link To Breast Cancer 2Health News:Heartburn Shadowing Modern India 2
(Date:8/25/2008)...Y HILLS, Mass., Aug. 25 /- Joseph F. ... of Spherics, Inc. ("Spherics") for,the benefit of...l,intellectual property will be sold at a sealed b...tended release formulation of Levodopa-Carbidopa t...kinson,s disease, with global,sales estimated at a...
(Date:8/25/2008)...O, Calif., Aug. 25 /- Anthera Pharmac...company developing,anti-inflammatory drugs, today ...urrent Acute coronary events with Near-term Cardio...designed to examine the impact of,varespladib when...ute,Coronary Syndrome (ACS) event., The FRANCIS t...
(Date:8/22/2008)...men Enrolled in Trial Sponsored by Medical Researc...FirstCall/ -- Indevus,Pharmaceuticals, Inc. (Nasda...lment in Protocol MDP 301, a Phase III clinical tr...icrobicide for the prevention of HIV and other,sex...ed by the United,Kingdom,s Medical Research Counci...
(Date:8/22/2008)...E, Md., Aug. 22 /- Human Ge...ed that it has completed the,enrollment and initia... of,HGS-ETR1 (mapatumumab) in combination with the... first-line therapy in advanced non-small cell,lun.../cgi-bin/prnh/20080416/HGSLOGO ), "There is an u...
Breaking Medicine Technology:Spherics, Inc. Offers Extended Release Formulation for Sustained and Stable Levodopa Levels 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 2Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 4Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 5Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 2Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 3Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 4Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 5RIVAs Cutting Edge Technology To Help Intermountain Healthcare Enhance Medication Delivery Safety 14295 1RIVAs Cutting Edge Technology To Help Intermountain Healthcare Enhance Medication Delivery Safety 14295 2HRSA Launches Digital Campaign to Promote Poison Awareness and Prevention 14292 1HRSA Launches Digital Campaign to Promote Poison Awareness and Prevention 14292 22007 Procedural Survey Reveals a Two Year Increase in Age of Patients Seeking Cosmetic Surgery 14289 12007 Procedural Survey Reveals a Two Year Increase in Age of Patients Seeking Cosmetic Surgery 14289 2Rodent study finds artificial butter chemical harmful to lungs 14287 1Rodent study finds artificial butter chemical harmful to lungs 14287 2
...Maintained Improvement in Personal and Social,Pe...07 /PRNewswire/ --,Longer-term treatment with IN..., a new once daily oral medication for,schizophr...ir,symptoms and maintain their improvements in p... data are from a large, open label, international,...
...nforce Astellas Commitment to Overcoming Critical,...many, April 02, 2007 /PRNewswire/ --Study results,...l Microbiology,and Infectious Diseases (ECCMID) sh...gal micafungin, both have the potential,to meet a ...s,hospital-acquired infections (HAIs). , Hospital-...
Other Medicine Technology:Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 2Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 3Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 4Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 5Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 6Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 2Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 3Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 4Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 5
The new PERIMOUNT Magna heart valve (bioprosthesis), with its true supra-annular design, offers optimal hemodynamics and flow characteristics for treatment of aortic heart valve disease.
... in high performance ultrasound design provides un...Echocardiography imaging requires superior spatial...er performance. The Terason Echo Ultrasound System...ecture, delivers a compact imaging platform withou...
...mplified In-office. Information. In real time. The...definitive indications of elevated vaginal fluid p...The innovative format is easy to use and delivers ...rub a swab containing unprocessed vaginal fluid ac...
For the quantitative determination of human MMP-9/NGAL Complex concentrations in cell culture supernates, serum,plasma, urine and saliva.
Medicine Products: